HIV prevention and care for youth in Uganda
Part of Infections clinical trials.
This study tests ways to help young people in Uganda prevent HIV or stay healthy if they already have HIV. It offers free prevention pills or injections and care for those living with HIV.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 15 and 24 years old.
- You are at high risk of getting HIV (not living with HIV) or you already have HIV and need treatment.
- You are willing to take medicine to prevent HIV (PrEP) or to treat HIV (ART).
- You have tested negative for HIV at the start of the study (if not living with HIV).
- You do not plan to move away from the study area in the next 6 months.
- You are willing to give written permission to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing different ways to encourage people who are at higher risk for HIV to get retested regularly. If you are HIV-negative and get tested at a participating clinic, you may be eligible.
This research tests a tool that helps women and their partners make informed decisions about PrEP (a daily pill that prevents HIV). The study involves healthcare workers, patients, and leaders in Uganda to improve how women choose and use HIV prevention.
This study offers different forms of HIV prevention medicine (PrEP) to young women ages 18–30 who are visiting clinics for reproductive health services like family planning or postnatal care. It aims to see which delivery method works best for you.
This study tests a support program to help young women stick with their HIV prevention medicine (PrEP). It aims to see if extra support helps them keep taking it regularly.
This study tests whether a long-acting injectable HIV medicine (given every couple of months) and teen support clubs can help adolescents stay healthy and engaged in care. If you are a teen living with HIV, this trial may offer a more convenient treatment option.
This study helps young people who are at risk for HIV get on PrEP—a daily pill or shot that prevents HIV. It tests different ways to help you start and stay on PrEP, with care available at clinics or in your community.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.